Akeso Investor Relations Material
Latest events
H2 2024
Akeso
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Akeso Inc
Access all reports
Akeso Inc is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of innovative therapies. The company focuses on oncology, immunology, and other therapeutic areas, utilizing its proprietary research platforms to develop monoclonal antibody drugs. The company is headquartered in Zhongshan, China, and its shares are listed on the SEHK.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
9926
Country
🇭🇰 Hong Kong